- Cannabinoid receptors as target for treatment of osteoporosis: A tale of two therapies (PubMed)
- Cannabinoids and bone: Friend or foe? (PubMed)
- Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells(PubMed)
- Cannabinoids and the skeleton: From marijuana to reversal of bone loss (PubMed)
- The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy(PubMed)
- The endovanilloid/endocannabinoid system in human osteoclasts: Possible involvement in bone formation and resorption (PubMed)
- Endocannabinoids and the regulation of bone metabolism (PubMed)
- Cannabinoid receptors and the regulation of bone mass (PubMed)
- Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health (PubMed)
- Peripheral cannabinoid receptor, CB2, regulates bone mass (PubMed)
- Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors (PubMed)
- Long-chain polyunsaturated fatty acids may mutually benefit both obesity and osteoporosis(PubMed)
- Skeletal lipidomics: Regulation of bone metabolism by fatty acid amide family(PubMed)